Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.
暂无分享,去创建一个
H. Koepsell | C. Lanvers-Kaminsky | H. Jürgens | H. Pavenstädt | A. am Zehnhoff-Dinnesen | A. Knief | D. Deuster | M. Sperling | E. Schlatter | B. Edemir | A. Schinkel | G. Ciarimboli | M. Holtkamp | Michael Holtkamp
[1] A. Sparreboom,et al. Contribution of Organic Cation Transporter 2 (OCT2) to Cisplatin‐Induced Nephrotoxicity , 2009, Clinical pharmacology and therapeutics.
[2] H. Koepsell,et al. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule. , 2009, American journal of physiology. Renal physiology.
[3] R. Murphy,et al. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. , 2009, American journal of physiology. Renal physiology.
[4] B. Blair,et al. The Role of the Mammalian Copper Transporter 1 in the Cellular Accumulation of Platinum-Based Drugs , 2009, Molecular Pharmacology.
[5] G. Ciarimboli. Organic cation transporters , 2008, Xenobiotica; the fate of foreign compounds in biological systems.
[6] Z. Dong,et al. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. , 2008, Kidney international.
[7] A. Trinidad,et al. Blebs in inner and outer hair cells: a pathophysiological hypothesis , 2008, The Journal of Laryngology & Otology.
[8] J. Hughes,et al. Identification and quantification of apoptosis in the kidney using morphology, biochemical and molecular markers , 2007, Nephrology.
[9] S. Masuda,et al. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. , 2007, Biochemical pharmacology.
[10] M. Dolan,et al. Molecular mechanisms of resistance and toxicity associated with platinating agents. , 2007, Cancer treatment reviews.
[11] S. Masuda,et al. Cisplatin and Oxaliplatin, but Not Carboplatin and Nedaplatin, Are Substrates for Human Organic Cation Transporters (SLC22A1–3 and Multidrug and Toxin Extrusion Family) , 2006, Journal of Pharmacology and Experimental Therapeutics.
[12] Shuzhong Zhang,et al. Organic cation transporters are determinants of oxaliplatin cytotoxicity. , 2006, Cancer research.
[13] R. Kerb. Implications of genetic polymorphisms in drug transporters for pharmacotherapy. , 2006, Cancer letters.
[14] J. Petrick,et al. TISSUE DISTRIBUTION AND ONTOGENY OF ORGANIC CATION TRANSPORTERS IN MICE , 2006, Drug Metabolism and Disposition.
[15] S. Masuda,et al. Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat. , 2005, Biochemical pharmacology.
[16] T. Ludwig,et al. Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2. , 2005, The American journal of pathology.
[17] Dong Wang,et al. Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.
[18] R. Skinner. Best practice in assessing ototoxicity in children with cancer. , 2004, European journal of cancer.
[19] S. Mildenberger,et al. NHE3 Na+/H+ exchanger supports proximal tubular protein reabsorption in vivo. , 2004, American journal of physiology. Renal physiology.
[20] Thomas Ludwig,et al. Nephrotoxicity of platinum complexes is related to basolateral organic cation transport. , 2004, Kidney international.
[21] H. Koepsell,et al. The SLC22 drug transporter family , 2004, Pflügers Archiv.
[22] E. Rubel,et al. A new method for imaging and 3D reconstruction of mammalian cochlea by fluorescent confocal microscopy , 2004, Brain Research.
[23] A. Schinkel,et al. Deficiency in the Organic Cation Transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in Mice Abolishes Renal Secretion of Organic Cations , 2003, Molecular and Cellular Biology.
[24] G. Ramesh,et al. TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity , 2002 .
[25] Hideyuki Saito,et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. , 2002, Journal of the American Society of Nephrology : JASN.
[26] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[27] A. Forge,et al. Differential vulnerability of basal and apical hair cells is based on intrinsic susceptibility to free radicals , 2001, Hearing Research.
[28] D. Kang,et al. Cisplatin decreases the abundance of aquaporin water channels in rat kidney. , 2001, Journal of the American Society of Nephrology : JASN.
[29] M. Donowitz,et al. Transepithelial resistance can be regulated by the intestinal brush-border Na(+)/H(+) exchanger NHE3. , 2000, American journal of physiology. Cell physiology.
[30] L. Endrenyi,et al. Repeat Administration of Drugs as a Means to Assess the Genetic Component in Pharmacological Variability , 1999, Pharmacology.
[31] R. Dobie,et al. Cis‐platinum ototoxicity in children , 1991, The Laryngoscope.
[32] M. Koyama,et al. An improved colorimetric assay for interleukin 2. , 1986, Journal of immunological methods.
[33] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[34] Y. Kuo,et al. Copper transport protein (Ctr1) levels in mice are tissue specific and dependent on copper status. , 2006, The Journal of nutrition.
[35] S. Howell,et al. Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs. , 2005, Critical reviews in oncology/hematology.
[36] H. Koepsell,et al. Organic cation transporters. , 2003, Reviews of physiology, biochemistry and pharmacology.
[37] Thomas D. Schmittgen,et al. Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .